WT Wu, YH Liu, S Zeng *, Y Han *, H Shen *. Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes. J Hematol Oncol. 2021 Oct 7; 14(1): 160.
发布时间:2023-03-08
点击次数:
是否译文:否
上一条: CJ Cai, DY Tang, Y Han, Edward Shen, O Abdihamid Ahmed, C Guo, H Shen *, S Zeng *. A comprehensive analysis of the fatal toxic effects associated with CD19 CAR-T cell therapy. Aging - US. 2020 Sep 24; 12(18):18741-18753.
下一条: JY Ma, LJ Huang, D Hu, S Zeng *, Y Han *, H Shen *. The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor? J Exp Clin Cancer Res. 2021 Oct 16; 40(1): 327.